T. Eren Et Al. , "Effectiveness of first line treatment with modified docetaxel cisplatin 5 Fluorouracil in advanced gastric cancer," 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress , 2012
Eren, T. Et Al. 2012. Effectiveness of first line treatment with modified docetaxel cisplatin 5 Fluorouracil in advanced gastric cancer. 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress .
Eren, T., ÖZDEMİR, N., YAZICI, O., Köş, F. T., Civelek, B., Yaman, Ş., ... ŞENDUR, M. A. N.(2012). Effectiveness of first line treatment with modified docetaxel cisplatin 5 Fluorouracil in advanced gastric cancer . 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress
Eren, Tülay Et Al. "Effectiveness of first line treatment with modified docetaxel cisplatin 5 Fluorouracil in advanced gastric cancer," 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, 2012
Eren, Tülay Et Al. "Effectiveness of first line treatment with modified docetaxel cisplatin 5 Fluorouracil in advanced gastric cancer." 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress , 2012
Eren, T. Et Al. (2012) . "Effectiveness of first line treatment with modified docetaxel cisplatin 5 Fluorouracil in advanced gastric cancer." 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress .
@conferencepaper{conferencepaper, author={Tülay Eren Et Al. }, title={Effectiveness of first line treatment with modified docetaxel cisplatin 5 Fluorouracil in advanced gastric cancer}, congress name={1st Near East and Association of Medical Oncology Socieities (NEMA) Congress}, city={}, country={}, year={2012}}